JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1986; 65:147-153
© 1986 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stoelting, R. K.
Right arrow Articles by Merin, R. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Stoelting, R. K.
Right arrow Articles by Merin, R. G.

Hepatic Dysfunction after Isoflurane Anesthesia

Robert K. Stoelting, MD, Casey D. Blitt, MD, Peter J. Cohen, MD, and Robert G. Merin, MD

Department of Anesthesia, Indiana University School of Medicine, Indianapolis, Indiana; Old Pueblo Anesthesia, Ltd., Tucson, Arizona; the Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; and the University of Texas Health Science Center at Houston, Houston, Texas.

Abstract

Four members of the Anesthetic and Life Support Advisory Committee of the Food and Drug Administration assessed the contribution of isoflurane (Forane®) to 45 instances of hepatic dysfunction after isoflurane anesthesia reported to the FDA for 1981–1984. For 29 (64%) of the cases, at least three members concluded that nonanesthetic causes (e.g., hypoxia, sepsis, viral infection) explained the hepatic injury. For 16 cases (36%), two or more members concluded that isoflurane might be one of several possible causes of the hepatic injury. In the latter cases, patients tended to be younger, had undergone anesthesia of shorter duration for operations outside the chest and abdomen, had developed symptoms later, had higher plasma transaminase values but lower bilirubin values, and had a lower incidence of eosinophilia, anemia, transfusions, and congestive heart failure. The committee concluded that current evidence does not indicate a reasonable likelihood of an association between the use of isoflurane and the occurrence of postoperative hepatic dysfunction.

Key Words: ANESTHETICS, volatile—isoflurane. • LIVER—isoflurane effects.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1986 by the International Anesthesia Research Society.